Repeated intracerebroventricular administration of β-amyloid25-35 to rats decreases muscarinic receptors in cerebral cortex

Neuroscience Letters

Volumn 278, Issue 1-2, 2000, Pages 69-72

  Pavia J ^a   Alberch, J ^b   Alvarez I ^c   Toledano, A ^c   De Ceballos, M L ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Amyloid; Acetylcholinesterase; Alzheimer's disease; Choline acetyltransferase; Muscarinic receptors

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; NONHUMAN; OLIVARY NUCLEUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANIMALS; BASAL NUCLEUS OF MEYNERT; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DOWN-REGULATION; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LEARNING; MALE; MEMORY; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RECEPTORS, PRESYNAPTIC;

EID: 0033988554     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00900-3     Document Type: Article

References (24)

1. Abe E., Casamenti F., Giovannelli, Scali C., Pepeu C. Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from the hippocampus in vivo. Neurosci. Lett. 636:1994;162-164.
2. Coyle J.T., Price D.L., De Long M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
3. Davies P., Verth A.H. Regional distribution of muscarinic acetylcholine receptors in normal and Alzheimer's type dementia brains. Brain Res. 138:1978;385-392.
4. Emre M., Geula C., Ransil B.J., Mesulam M.-M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-Amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-559.
5. Everitt B.J., Robbins T.W. Central cholinergic system and cognition. Annu. Rev. Psychol. 48:1997;649-684.
6. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 14:1991;230-233.
7. Flynn D.D., Ferrari-DiLeo G., Mash D.C., Levey A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem. 64:1995;1888-1891.
8. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
9. Frautschy S.A., Baird A., Cole G.M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;8362-8366.
10. Freeman J.J., Hayes E.P. Microsomal metabolism of acetonitrile to cyanide. Biochem. Pharmacol. 37:1988;1153-1159.
11. Giordano T., Pan J.B., Monteggia L.M., Holzman T.F., Snyder S.T., Krafft G., Ghanbari H., Kowall N. Similarities between β Amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp. Neurol. 125:1994;175-182.
12. Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience. 66:1995;781-792.
13. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., Nabeshima T. Dysfuntion of cholinergic and dopaminergic neuronal systems in β-Amyloid protein-infused rats. J. Neurochem. 66:1996;1113-1117.
14. Toledano A., Bentura M.L. Pyritinol facilitates the recovery of cortical cholinergic deficits caused by nucleus basalis lesions. J. Neural. Transm. 7:1994;195-209.
15. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;7247-7251.
16. Mash D.C., Flynn D.D., Potter L.T. Loss of M1 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 228:1985;1115-1117.
17. Morimoto K., Yoshimi K., Tonohiro T., Yamada N., Oda T., Kaneko I. Co-injection of β-Amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Neuroscience. 84:1998;479-487.
18. Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170:1994;63-66.
19. Palacios J.M. Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia. Brain Res. 243:1982;173-175.
20. Pavia J., de Ceballos M.L., Sanchez de la Cuesta F. Alzheimer's disease: relationship between muscarinic cholinergic receptors, β-amyloid and tau proteins. Fundam. Clin. Pharmacol. 12:1998;473-481.
21. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-Amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
22. Reisine T.D., Yamamura H.I., Bird E.D., Spokes E., Enna S.J. Pre- and post-synaptic neurochemical alterations in Alzheimer's disease. Brain Res. 159:1978;477-480.
23. Waite J., Cole G.M., Fraustchy S.A., Connor D.J., Thal L.J. Solvent effects on beta protein toxicity in vivo. Neurobiol. Aging. 13:1992;595-599.
24. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid-β-protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.